Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity

The present research work was designed to prepare butenafine (BN)-loaded bilosomes (BSs) by the thin-film hydration method. BN is a sparingly water-soluble drug having low permeability and bioavailability. BSs are lipid-based nanovesicles used to entrap water-insoluble drugs for enhanced permeation...

Full description

Bibliographic Details
Main Authors: Ameeduzzafar Zafar, Syed Sarim Imam, Nabil K. Alruwaili, Mohd Yasir, Omar Awad Alsaidan, Sultan Alshehri, Mohammed M. Ghoneim, Mohammad Khalid, Ali Alquraini, Salman S. Alharthi
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/8/2/133
_version_ 1827654730299473920
author Ameeduzzafar Zafar
Syed Sarim Imam
Nabil K. Alruwaili
Mohd Yasir
Omar Awad Alsaidan
Sultan Alshehri
Mohammed M. Ghoneim
Mohammad Khalid
Ali Alquraini
Salman S. Alharthi
author_facet Ameeduzzafar Zafar
Syed Sarim Imam
Nabil K. Alruwaili
Mohd Yasir
Omar Awad Alsaidan
Sultan Alshehri
Mohammed M. Ghoneim
Mohammad Khalid
Ali Alquraini
Salman S. Alharthi
author_sort Ameeduzzafar Zafar
collection DOAJ
description The present research work was designed to prepare butenafine (BN)-loaded bilosomes (BSs) by the thin-film hydration method. BN is a sparingly water-soluble drug having low permeability and bioavailability. BSs are lipid-based nanovesicles used to entrap water-insoluble drugs for enhanced permeation across the skin. BSs were prepared by the thin-film hydration method and optimized by the Box–Behnken design (BBD) using lipid (A), span 60 (B), and sodium deoxycholate (C) as independent variables. The selected formulation (BN-BSo) was converted into the gel using Carbopol 940 as a gelling agent. The prepared optimized gel (BN-BS-og) was further evaluated for the gel characterization, drug release, drug permeation, irritation, and anti-fungal study. The optimized bilosomes (BN-BSo) showed a mean vesicle size of 215 ± 6.5 nm and an entrapment efficiency of 89.2 ± 1.5%. The DSC study showed that BN was completely encapsulated in the BS lipid matrix. BN-BSog showed good viscosity, consistency, spreadability, and pH. A significantly (<i>p</i> < 0.05) high release (81.09 ± 4.01%) was achieved from BN-BSo compared to BN-BSog (65.85 ± 4.87%) and pure BN (17.54 ± 1.37 %). The permeation study results revealed that BN-BSo, BN-BSog, and pure BN exhibited 56.2 ± 2.7%, 39.2 ± 2.9%, and 16.6 ± 2.3%. The enhancement ratio of permeation flux was found to be 1.4-fold and 3.4-fold for the BN-BS-og and pure BN dispersion. The HET-CAM study showed that BN-BSog was found to be nonirritant as the score was found within the limit. The antifungal study revealed a significant (<i>p</i> < 0.05) enhanced antifungal activity against <i>C. albicans</i> and <i>A. niger</i>. The findings of the study revealed that BS is an important drug delivery system for transdermal delivery.
first_indexed 2024-03-09T21:53:55Z
format Article
id doaj.art-90c96e8381f94832bacfd0fac405d7c6
institution Directory Open Access Journal
issn 2310-2861
language English
last_indexed 2024-03-09T21:53:55Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj.art-90c96e8381f94832bacfd0fac405d7c62023-11-23T20:02:22ZengMDPI AGGels2310-28612022-02-018213310.3390/gels8020133Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal ActivityAmeeduzzafar Zafar0Syed Sarim Imam1Nabil K. Alruwaili2Mohd Yasir3Omar Awad Alsaidan4Sultan Alshehri5Mohammed M. Ghoneim6Mohammad Khalid7Ali Alquraini8Salman S. Alharthi9Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi ArabiaDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi ArabiaDepartment of Pharmacy, College of Health Science, Arsi University, Asella 396, EthiopiaDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Al-Jouf, Saudi ArabiaDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacy Practice, College of Pharmacy, Almaarefa University, Ad Diriyah 13713, Saudi ArabiaDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi ArabiaDepartment of Pharmaceutical Chemistry, Faculty of Clinical Pharmacy, Al Baha University, Al Baha 65779, Saudi ArabiaDepartment of Pharmacy, Security Forces Hospital Program, Riyadh 11481, Saudi ArabiaThe present research work was designed to prepare butenafine (BN)-loaded bilosomes (BSs) by the thin-film hydration method. BN is a sparingly water-soluble drug having low permeability and bioavailability. BSs are lipid-based nanovesicles used to entrap water-insoluble drugs for enhanced permeation across the skin. BSs were prepared by the thin-film hydration method and optimized by the Box–Behnken design (BBD) using lipid (A), span 60 (B), and sodium deoxycholate (C) as independent variables. The selected formulation (BN-BSo) was converted into the gel using Carbopol 940 as a gelling agent. The prepared optimized gel (BN-BS-og) was further evaluated for the gel characterization, drug release, drug permeation, irritation, and anti-fungal study. The optimized bilosomes (BN-BSo) showed a mean vesicle size of 215 ± 6.5 nm and an entrapment efficiency of 89.2 ± 1.5%. The DSC study showed that BN was completely encapsulated in the BS lipid matrix. BN-BSog showed good viscosity, consistency, spreadability, and pH. A significantly (<i>p</i> < 0.05) high release (81.09 ± 4.01%) was achieved from BN-BSo compared to BN-BSog (65.85 ± 4.87%) and pure BN (17.54 ± 1.37 %). The permeation study results revealed that BN-BSo, BN-BSog, and pure BN exhibited 56.2 ± 2.7%, 39.2 ± 2.9%, and 16.6 ± 2.3%. The enhancement ratio of permeation flux was found to be 1.4-fold and 3.4-fold for the BN-BS-og and pure BN dispersion. The HET-CAM study showed that BN-BSog was found to be nonirritant as the score was found within the limit. The antifungal study revealed a significant (<i>p</i> < 0.05) enhanced antifungal activity against <i>C. albicans</i> and <i>A. niger</i>. The findings of the study revealed that BS is an important drug delivery system for transdermal delivery.https://www.mdpi.com/2310-2861/8/2/133butenafinebilosomespermeationirritation studyantifungal activity
spellingShingle Ameeduzzafar Zafar
Syed Sarim Imam
Nabil K. Alruwaili
Mohd Yasir
Omar Awad Alsaidan
Sultan Alshehri
Mohammed M. Ghoneim
Mohammad Khalid
Ali Alquraini
Salman S. Alharthi
Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity
Gels
butenafine
bilosomes
permeation
irritation study
antifungal activity
title Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity
title_full Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity
title_fullStr Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity
title_full_unstemmed Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity
title_short Formulation and Evaluation of Topical Nano-Lipid-Based Delivery of Butenafine: In Vitro Characterization and Antifungal Activity
title_sort formulation and evaluation of topical nano lipid based delivery of butenafine in vitro characterization and antifungal activity
topic butenafine
bilosomes
permeation
irritation study
antifungal activity
url https://www.mdpi.com/2310-2861/8/2/133
work_keys_str_mv AT ameeduzzafarzafar formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT syedsarimimam formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT nabilkalruwaili formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT mohdyasir formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT omarawadalsaidan formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT sultanalshehri formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT mohammedmghoneim formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT mohammadkhalid formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT alialquraini formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity
AT salmansalharthi formulationandevaluationoftopicalnanolipidbaseddeliveryofbutenafineinvitrocharacterizationandantifungalactivity